Comparison of short- and long-acting benzodiazepine-receptor agonists with different receptor selectivity on motor coordination and muscle relaxation following thiopental-induced anesthesia in mice

Journal of Pharmacological Sciences

Volumn 107, Issue 3, 2008, Pages 277-284

  Tanaka, Mamoru ^a   Suemaru, Katsuya ^a,b   Watanabe, Shinichi ^a   Cui, Ranji ^b   Li, Bingjin ^b   Araki, Hiroaki ^a,b  

^a EHIME UNIVERSITY HOSPITAL   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypnotics; Loss of righting reflex; Motor coordination; Muscle relaxant; Thiopental

Indexed keywords

BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; NITRAZEPAM; QUAZEPAM; RECEPTOR SUBTYPE; THIOPENTAL; TRIAZOLAM; ZOLPIDEM; ZOPICLONE;

ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HALF LIFE TIME; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; MUSCLE RELAXATION; NONHUMAN; RIGHTING REFLEX; ROTAROD TEST;

EID: 47749090534     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071991     Document Type: Article

References (36)

1. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis, I: psychotropic drugs. J Am Geriatr Soc. 1999;47:30-39.
2. Griffiths RR, Wolf B. Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol. 1990;10:237-243.
3. Korpi ER, Mattila MJ, Wisden W, Luddens H. GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzo-diazepine site ligands. Ann Med. 1998;29:275-282.
4. Belzung C, Barreau S, Agmo A. Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the rat. Eur J Pharmacol. 2000;394:289-294.
5. Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50:1629-1637.
6. Passaro A, Volpato S, Romagnoni F, Manzoli N, Zuliani G, Fellin R. Benzodiazepines with different half-life and falling in a hospitalized population: The GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano. J Clin Epidemiol. 2000;53: 1222-1229.
7. Roth T, Hartse K, Saab P, Piccione P, Kramer M. The effects of flurazepam, lorazepam, and triazolam on sleep and memory. Psychopharmacology (Berl). 1980;70:231-237.
8. Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc. 2000;48:682-685.
9. Philip SW, Rhonda LB, Robert JG, Helen M, Jerry A. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892-898.
10. Mehta AK, Ticku, MK. An update on GABAA receptors. Brain Res. 1999;29:196-217.
11. A receptor subtypes. Adv Pharmacol. 2006;54:231-263.
12. Niddam R, Dubois A, Scatton B, Arbilla S, Langer SZ. Auto-radiographic localization of [3H]zolpidem binding sites in the rat CNS: comparison with the distribution of [3H]flunitrazepam binding sites. J Neurochem. 1987;49:890-899.
13. Griebel G, Sanger DJ, Perrault G. The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands. Behav Pharmacol. 1996;6:732-745.
14. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1subtype. Nat Neurosci. 2000;3:587-592.
15. Dennis T, Dubois A, Benavides J, Scatton B. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An auto-radiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. J Pharmacol Exp Ther. 1998;247:309-322.
16. Langtry HD, Benfield P. Zolpidem; A review of its pharmaco-dynamic and pharmacokinetic properties and therapeutic potential. Drugs. 1990;40:291-313.
17. Langley MS, Clissold SP. Brotizolam; A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an hypnotic. Drugs. 1988;35:104-122.
18. McMahon LR, Gerak LR, Carter L, Ma C, Cook JM, France CP. Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys. J Pharmacol Exp Ther. 2002;300:505-512.
19. Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ. Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands. Behav Pharmacol. 1999;110: 483-495.
20. Pokk P, Zharkovsky A. The effects of drugs acting at GABA-benzodiazepine- barbiturate receptor complex on the behaviour of sleep-deprived mice. Pharmacol Toxicol. 1995;76:23-28.
21. Yemitan OK, Salahdeen HM. Neurosedative and muscle relaxant activities of aqueous extract of Bryophyllum pinnatum. Fitoterapia. 2005;76:187-193.
22. Carmichael FJ, Haas DA. General Anesthetics. In: Kalant H, Roschlau WHE, editors. Principles of medical pharmacology. 6th ed. New York: Oxford University Press; 1998. p. 278-292.
23. Villar R, Laguna M, Calleja JM, Cadavid I. Effect of Skeletonema statum extracts on the central nervous system. Planta Med. 1992;38:398-403.
24. Jones BJ, Roberts DJ. The quantitative measurement of motor incoordination in naive mice using an accelerating rota-rod. J Pharm Pharmacol. 1968;20:302-304.
25. Kern C, Weber A, Aurilio C, Forster A. Patient evaluation and comparison of the recovery profile between propofol and thiopentone as induction agents in day surgery. Anaesth Intensive Care. 1998;26:156-161.
26. Witzum JL, Evers AS, Crowder CM. General Anesthetics. In: Hardman JG, Gilman AG, Limbird LE, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 337-344.
27. Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature. 1999:401;796-800.
28. Bohlhalter S, Weinmann O, Mohler H, Fritschy JM. Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci. 1996;16:283-297.
29. Yasui M, Kato A, Kanemasa T, Murata S, Nishitomi K, Koike K, et al. Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes. Nihon Shinkei Seishin Yakurigaku Zasshi. 2005;25:143-151.
30. Benavides J, Peny B, Durand A, Arbilla S, Scatton B. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. J Pharmacol Exp Ther.1992;263:884-896.
31. Gomita Y, Morii M, Ichimaru Y, Moriyama M, Ueki S. [Behavioral and electroencephalographic study of 7-chloro-1-methyl-5-phenyl-1H-1, 5benzodiazepine-2,4-(3H,5H)-dione (clobazam).] Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi). 1983;82:267-292. (text in Japanese with English abstract)
32. Budhiraja S, Singh J. Adjuvant effect of melatonin on anesthesia induced by thiopental sodium, ketamine, and ether in rats. Methods Find Exp Clin Pharmacol. 2005;27:697-699.
33. Newman LM, Curran MA, Becker GL. Effects of chronic alcohol intake on anesthetic responses to diazepam and thiopental in rats. Anesthesiology. 1986;65:196-200.
34. Yemitan OK, Salahdeen HM. Neurosedative and muscle relaxant activities of aqueous extract of Bryophyllum pinnatum. Fitoterapia. 2005;76:187-193.
35. Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A. Association between psychoactive medications and delirium in hospitalized patients: a critical review. Psychosomatics. 2005;46:302-316.
36. Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, et al. Study of Osteoporotic Fractures Research Group. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50:1629-1637.